Is the re-use of sterilized implant abutments safe enough? (Implant abutment safety).


Journal

Medicina oral, patologia oral y cirugia bucal
ISSN: 1698-6946
Titre abrégé: Med Oral Patol Oral Cir Bucal
Pays: Spain
ID NLM: 101231694

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 08 01 2019
accepted: 08 02 2019
pubmed: 23 8 2019
medline: 27 11 2019
entrez: 22 8 2019
Statut: epublish

Résumé

The reuse of implant healing abutments is common in dental practice. Effective elimination of bacteria and viruses is accomplished by conventional sterilization. The aim of this work was to explore the eventual survival of microorganisms on sterilized healing abutments and to rule out the presence of transmissible organic material after standard procedures. A total of 55 healing abutments previously used in patients will be washed and sterilized in a steam autoclave at 121 C for 15 min. Each healing abutment will be cultured in Brain Heart Infusion broth (BHI) under strict aseptic conditions. Besides, two control groups will be included: one of 3 unused healing abutments, and the other of just medium. After 10 days at 37°C under a 5% CO2 100 µl of the broth will be plated on solid media (Brain Infusion Agar, BHIA) and Columbia Blood agar to test for sterility. The remaining volume will be centrifuged, the sediment fixed, and a Gram stain performed to discard the presence of non-cultivable microorganisms. Moreover, to determine the presence of remaining organic material after the cleaning and sterilizing treatments, the bioburden will be determined by measuring total organic carbon (TOC) in another 10 previously used healing abutments, cleaned and sterilized, that will be submerged in Milli-Q water and sonicated. No bacterial growth was detected on any of the 58 cultured abutments, indicating that the sterilization was completely satisfactory in terms of removal of live bacteria or spores. Nevertheless, significant amounts of organic carbon may still be recovered (up to 125,31 µg/abutment) after they have been sterilized. Significant amounts of the bioburden remained adhered to the surfaces in spite of the cleaning and sterilization procedures. Taking into account our results and data from other authors, the presence of infectious particles on the reused healing abutments such as prions cannot be ruled out.

Sections du résumé

BACKGROUND BACKGROUND
The reuse of implant healing abutments is common in dental practice. Effective elimination of bacteria and viruses is accomplished by conventional sterilization. The aim of this work was to explore the eventual survival of microorganisms on sterilized healing abutments and to rule out the presence of transmissible organic material after standard procedures.
MATERIAL AND METHODS METHODS
A total of 55 healing abutments previously used in patients will be washed and sterilized in a steam autoclave at 121 C for 15 min. Each healing abutment will be cultured in Brain Heart Infusion broth (BHI) under strict aseptic conditions. Besides, two control groups will be included: one of 3 unused healing abutments, and the other of just medium. After 10 days at 37°C under a 5% CO2 100 µl of the broth will be plated on solid media (Brain Infusion Agar, BHIA) and Columbia Blood agar to test for sterility. The remaining volume will be centrifuged, the sediment fixed, and a Gram stain performed to discard the presence of non-cultivable microorganisms. Moreover, to determine the presence of remaining organic material after the cleaning and sterilizing treatments, the bioburden will be determined by measuring total organic carbon (TOC) in another 10 previously used healing abutments, cleaned and sterilized, that will be submerged in Milli-Q water and sonicated.
RESULTS RESULTS
No bacterial growth was detected on any of the 58 cultured abutments, indicating that the sterilization was completely satisfactory in terms of removal of live bacteria or spores. Nevertheless, significant amounts of organic carbon may still be recovered (up to 125,31 µg/abutment) after they have been sterilized.
CONCLUSIONS CONCLUSIONS
Significant amounts of the bioburden remained adhered to the surfaces in spite of the cleaning and sterilization procedures. Taking into account our results and data from other authors, the presence of infectious particles on the reused healing abutments such as prions cannot be ruled out.

Identifiants

pubmed: 31433387
pii: 22967
doi: 10.4317/medoral.22967
pmc: PMC6764709
doi:

Substances chimiques

Dental Implants 0
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e583-e587

Références

Int J Prosthodont. 2018 Mar/Apr;31(2):161-162
pubmed: 29518810
J Oral Maxillofac Pathol. 2016 Jan-Apr;20(1):111-4
pubmed: 27194872
J Periodontol. 2018 Jun;89 Suppl 1:S291-S303
pubmed: 29926950
Clin Implant Dent Relat Res. 2016 Dec;18(6):1095-1102
pubmed: 26856530
PLoS Pathog. 2008 Nov;4(11):e1000206
pubmed: 19008948
Clin Oral Implants Res. 2013 Jun;24(6):606-11
pubmed: 22587335
Scanning. 2015 Nov-Dec;37(6):429-37
pubmed: 26148576
Eur J Prosthodont Restor Dent. 2015 Jun;23(2):62-9
pubmed: 26373199
J Clin Periodontol. 2011 Mar;38 Suppl 11:203-13
pubmed: 21323716
J Periodontol. 2016 Nov;87(11):1295-1304
pubmed: 27420109
Clin Oral Implants Res. 2014 Mar;25(3):328-336
pubmed: 23210704
Clin Implant Dent Relat Res. 2016 Dec;18(6):1069-1074
pubmed: 26640198
Implant Dent. 2015 Apr;24(2):174-9
pubmed: 25706262
Implant Dent. 2000;9(3):236-46
pubmed: 11307410
J Oral Implantol. 2017 Feb;43(1):8-11
pubmed: 27700696
J Endod. 2007 Apr;33(4):442-6
pubmed: 17368335
Int Microbiol. 2013 Dec;16(4):235-42
pubmed: 25102724
J Hosp Infect. 2012 Jan;80(1):46-51
pubmed: 22099953

Auteurs

M-A Sánchez-Garcés (MA)

Department of Pathology and Experimental Therapeutics, Feixa Llarga s/n. Pavelló de Govern, 5 planta, 08907 L'Hospitalet de Llobregat, Barcelona, Spain, tvinuesa@ub.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH